IO Biotech Inc.

AI Score

0

Unlock

0.88
-0.03 (-3.75%)
At close: Mar 05, 2025, 1:32 PM

IO Biotech Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 756K 540K n/a n/a n/a
Gross Profit -756K -540K n/a n/a n/a
Operating Income -91.44M -71.42M -41.23M -10.14M -9.91M
Interest Income 5.88M 1.41M 361.00 26.00 6.00
Pretax Income -85.23M -70.19M -67.81M -12.04M -10.74M
Net Income -86.08M -71.46M -67.88M -12.07M -10.75M
Selling & General & Admin 23.61M 24.44M 11.08M 1.68M 1.98M
Research & Development 67.83M 46.99M 30.15M 8.46M 7.94M
Other Expenses n/a n/a -26.54M -1.99M -781K
Operating Expenses 91.44M 71.42M 41.23M 10.14M 9.91M
Interest Expense n/a 302K 361K 26K 6K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 91.44M 71.42M 41.23M 10.14M 9.91M
Income Tax 852K 1.27M 68K 26K 6K
Shares Outstanding (Basic) 43.54M 28.82M 28.82M 28.82M 28.82M
Shares Outstanding (Diluted) 43.54M 28.82M 28.82M 28.82M 28.82M
EPS (Basic) -1.98 -2.48 -2.36 -0.42 -0.37
EPS (Diluted) -1.98 -2.48 -2.36 -0.42 -0.37
EBITDA -91.23M -69.34M -67.45M n/a -824K
Depreciation & Amortization 215K 540K 2K 10.14M 9.91M